Cover Image
市場調查報告書

中間葡萄膜炎:全球臨床實驗趨勢

Intermediate Uveitis Global Clinical Trials Review, H2, 2015

出版商 GlobalData 商品編碼 338376
出版日期 內容資訊 英文 89 Pages
訂單完成後即時交付
價格
Back to Top
中間葡萄膜炎:全球臨床實驗趨勢 Intermediate Uveitis Global Clinical Trials Review, H2, 2015
出版日期: 2015年07月24日 內容資訊: 英文 89 Pages
簡介

本報告提供中間葡萄膜炎臨床實驗最新趨勢相關分析,提供您各地區的臨床實驗數量,臨床實驗的各階段進展,實驗對象採用狀況,彙整有潛力的贊助商,各企業和研究機關的研究進展,有潛力的藥劑比較等資訊。

簡介

  • 中間葡萄膜炎
  • 本報告概要

各地區的臨床實驗情形

  • 各國臨床實驗數量和平均實驗人數
    • 亞太地區主要5國的臨床實驗數量
    • 歐洲主要5國的臨床實驗數量
    • 北美主要國家的臨床實驗數量
    • 中東·非洲的主要5個國家臨床實驗數量
    • 中南美的主要5個國家臨床實驗數量

G7各國臨床實驗數量:眼科疾病治療藥臨床實驗上中間葡萄膜炎的比例

G7各國的各階段臨床實驗數量

G7各國臨床實驗數量:各進展狀況

E7各國臨床實驗數量:眼科疾病治療藥臨床實驗上中間葡萄膜炎的比例

E7各國的各階段臨床實驗數量

E7各國臨床實驗數量:各進展狀況

各階段臨床實驗數量

  • 進行中的臨床實驗:各階段

各進展狀況臨床實驗數量

臨床實驗的目標達成情形

未完成的臨床實驗數量

一定期間所採用的實驗對象

贊助商類別的臨床實驗數量

有潛力的贊助商

中間葡萄膜炎治療藥臨床實驗的主要參與企業

有潛力的藥劑

臨床實驗簡介

  • 主要企業臨床實驗概要
    • Novartis AG
    • XOMA Corporation
    • AbbVie Inc.
    • Santen Pharmaceutical Co., Ltd.
    • Lux Biosciences, Inc.
    • Jaguar Holding Company II
    • Excel Life Sciences, Inc.
    • Clearside BioMedical, Inc.
    • Cerimon Pharmaceuticals, Inc.
    • Allergan Plc
  • 有代表性的研究機關·醫院臨床實驗概要
    • The Johns Hopkins University
    • Duke University Medical Center
    • National Eye Institute
    • University of Heidelberg

5個有代表性的臨床實驗簡介

附錄

目錄
Product Code: GDHC2790CTIDB

GlobalData's clinical trial report, "Intermediate Uveitis Global Clinical Trials Review, H2, 2015" provides an overview of Intermediate Uveitis clinical trials scenario. This report provides top line data relating to the clinical trials on Intermediate Uveitis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using Global Data's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Intermediate Uveitis
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Five Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Five Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Intermediate Uveitis to Ophthalmology Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Intermediate Uveitis to Ophthalmology Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Intermediate Uveitis
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Intermediate Uveitis Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • Novartis AG
      • Clinical Trial Overview of Novartis AG
      • XOMA Corporation
      • Clinical Trial Overview of XOMA Corporation
      • AbbVie Inc.
      • Clinical Trial Overview of AbbVie Inc.
      • Santen Pharmaceutical Co., Ltd.
      • Clinical Trial Overview of Santen Pharmaceutical Co., Ltd.
      • Lux Biosciences, Inc.
      • Clinical Trial Overview of Lux Biosciences, Inc.
      • Jaguar Holding Company II
      • Clinical Trial Overview of Jaguar Holding Company II
      • Excel Life Sciences, Inc.
      • Clinical Trial Overview of Excel Life Sciences, Inc.
      • Clearside BioMedical, Inc.
      • Clinical Trial Overview of Clearside BioMedical, Inc.
      • Cerimon Pharmaceuticals, Inc.
      • Clinical Trial Overview of Cerimon Pharmaceuticals, Inc.
      • Allergan Plc
      • Clinical Trial Overview of Allergan Plc
    • Clinical Trial Overview of Top Institutes / Government
      • The Johns Hopkins University
      • Clinical Trial Overview of The Johns Hopkins University
      • Duke University Medical Center
      • Clinical Trial Overview of Duke University Medical Center
      • National Eye Institute
      • Clinical Trial Overview of National Eye Institute
      • University of Heidelberg
      • Clinical Trial Overview of University of Heidelberg
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Intermediate Uveitis Therapeutics, Global, Clinical Trials by Region, 2015*
  • Intermediate Uveitis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015*
  • Intermediate Uveitis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015*
  • Intermediate Uveitis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015*
  • Intermediate Uveitis Therapeutics Clinical Trials, Europe, Top Five Countries, 2015*
  • Intermediate Uveitis Therapeutics Clinical Trials, North America, Top Countries, 2015*
  • Intermediate Uveitis Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2015*
  • Intermediate Uveitis Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2015*
  • Proportion of Intermediate Uveitis to Ophthalmology Clinical Trials, G7 Countries (%), 2015*
  • Intermediate Uveitis Therapeutics, G7 Countries, Clinical Trials by Phase, 2015*
  • Intermediate Uveitis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015*
  • Proportion of Intermediate Uveitis to Ophthalmology Clinical Trials, E7 Countries (%), 2015*
  • Intermediate Uveitis Therapeutics, E7 Countries, Clinical Trials by Phase, 2015*
  • Intermediate Uveitis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015*
  • Intermediate Uveitis Therapeutics, Global, Clinical Trials by Phase, 2015*
  • Intermediate Uveitis Therapeutics, Global, Clinical Trials In Progress by Phase 2015*
  • Intermediate Uveitis Therapeutics, Global, Clinical Trials by Trial Status, 2015*
  • Intermediate Uveitis Therapeutics Clinical Trials, Global, by End Point Status, 2015*
  • Intermediate Uveitis Therapeutics, Global, Withdrawn Clinical Trials, 2015*
  • Intermediate Uveitis Therapeutics, Global, Terminated Clinical Trials, 2015*
  • Intermediate Uveitis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
  • Intermediate Uveitis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015*
  • Intermediate Uveitis Therapeutics Clinical Trials, Global, Key Sponsors, 2015*
  • Intermediate Uveitis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015*
  • Intermediate Uveitis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015*
  • Intermediate Uveitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2015*
  • Intermediate Uveitis Therapeutics Clinical Trials Market, Global, Clinical Trials by XOMA Corporation, 2015*
  • Intermediate Uveitis Therapeutics Clinical Trials Market, Global, Clinical Trials by AbbVie Inc., 2015*
  • Intermediate Uveitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Santen Pharmaceutical Co., Ltd., 2015*
  • Intermediate Uveitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Lux Biosciences, Inc., 2015*
  • Intermediate Uveitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Jaguar Holding Company II, 2015*
  • Intermediate Uveitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Excel Life Sciences, Inc., 2015*
  • Intermediate Uveitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Clearside BioMedical, Inc., 2015*
  • Intermediate Uveitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Cerimon Pharmaceuticals, Inc., 2015*
  • Intermediate Uveitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Allergan Plc, 2015*
  • Intermediate Uveitis Therapeutics Clinical Trials Market, Global, Clinical Trials by The Johns Hopkins University, 2015*
  • Intermediate Uveitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Duke University Medical Center, 2015*
  • Intermediate Uveitis Therapeutics Clinical Trials Market, Global, Clinical Trials by National Eye Institute, 2015*
  • Intermediate Uveitis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Heidelberg, 2015*

List of Figures

  • Intermediate Uveitis Therapeutics, Global, Clinical Trials by Region (%), 2015*
  • Intermediate Uveitis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015*
  • Intermediate Uveitis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015*
  • Intermediate Uveitis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015*
  • Intermediate Uveitis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015*
  • Intermediate Uveitis Therapeutics Clinical Trials, North America, Top Countries (%), 2015*
  • Intermediate Uveitis Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2015*
  • Intermediate Uveitis Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2015*
  • Proportion of Intermediate Uveitis to Ophthalmology Clinical Trials, G7 Countries (%), 2015*
  • Intermediate Uveitis Therapeutics, G7 Countries, Clinical Trials by Phase, 2015*
  • Intermediate Uveitis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015*
  • Proportion of Intermediate Uveitis to Ophthalmology Clinical Trials, E7 Countries (%), 2015*
  • Intermediate Uveitis Therapeutics, E7 Countries, Clinical Trials by Phase, 2015*
  • Intermediate Uveitis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015*
  • Intermediate Uveitis Therapeutics, Global, Clinical Trials by Phase (%), 2015*
  • Intermediate Uveitis Therapeutics, Global, Clinical Trials In Progress by Phase, 2015*
  • Intermediate Uveitis Therapeutics, Global, Clinical Trials by Trial Status, 2015*
  • Intermediate Uveitis Therapeutics Clinical Trials, Global, by End Point Status, 2015*
  • Intermediate Uveitis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
  • Intermediate Uveitis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015*
  • Intermediate Uveitis Therapeutics Clinical Trials, Global, Key Sponsors, 2015*
  • Intermediate Uveitis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015*
  • Intermediate Uveitis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015*
  • GlobalData Methodology
Back to Top